End-to-end Expertise: Handling the Entire Journey from Conception to Approval
2023-07-19
Newsletter
2023-07-19
Newsletter
🌍 Innovaderm is excited to attend the European Alliance of Associations for Rheumatology (EULAR) Congress for the first time! Our teams will be in Vienna from June 12th to 15th to discuss and meet with you. 🤝🏽 Connect with us to schedule some time with Dr. Jasmina Jankicevic, Magdalena Krol, Anne Marie Gaulin, Karine Danielyan and […]
Innovaderm is excited to share a glowing testimonial from Ventyx Biosciences! "We would like to express our gratitude for the exceptional partnership we’ve had with Innovaderm. Our collaboration on a phase 2 study for moderate to severe plaque psoriasis was nothing short of remarkable. The expertise and motivation Innovaderm brought to the table were pivotal […]
Innovaderm’s expertise will be highlighted once more during a late-breaking session at the 2024 Society for Investigative Dermatology (SID) annual meeting in Dallas, Texas. Results of this Pfizer-sponsored trial will be presented at the annual event, on Friday, May 17, 2024. C3941005 study title: A phase 2b, randomized, double blind, vehicle controlled, parallel group study to assess […]